首页 > 最新文献

Journal of Clinical Outcomes Management最新文献

英文 中文
A COVID-19 Clinical Management Committee to Standardize Care in a 2-Hospital System 新冠肺炎临床管理委员会将在2医院系统中标准化护理
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.12788/jcom.0079
Meisenberg
Objective: The COVID-19 pandemic has been a challenge for hospital medical staffs worldwide due to high volumes of patients acutely ill with novel syndromes and prevailing uncertainty regarding optimum supportive and therapeutic interventions. Additionally, the response to this crisis was driven by a plethora of nontraditional information sources, such as email chains, websites, non-peer-reviewed preprints, and press releases. Care patterns became idiosyncratic and often incorporated unproven interventions driven by these nontraditional information sources. This report evaluates the efforts of a health system to create and empower a multidisciplinary committee to develop, implement, and monitor evidence-based, standardized protocols for patients with COVID-19. Method(s): This report describes the composition of the committee, its scope, and its important interactions with the health system pharmacy and therapeutics committee, research teams, and other work groups planning other aspects of COVID-19 management. It illustrates how the committee was used to demonstrate for trainees the process and value of critically examining evidence, even in a chaotic environment. Result(s): Data show successful interventions in reducing excessive ordering of certain laboratory tests, reduction of nonrecommended therapies, and rapid uptake of evidence-based or guidelines-supported interventions. Conclusion(s): A multidisciplinary committee dedicated solely to planning, implementing, and monitoring standard approaches that eventually became evidence-based decision-making led to an improved focus on treatment options and outcomes for COVID-19 patients. Data presented illustrate the attainable success of a committee that is both adaptable and suitable for similar emergencies in the future. Copyright © 2022 Turner White Communications Inc.. All rights reserved.
目的:COVID-19大流行对世界各地的医院医务人员来说是一个挑战,因为大量患有新型综合征的急性患者,以及在最佳支持和治疗干预措施方面普遍存在不确定性。此外,对这场危机的反应是由大量非传统信息来源驱动的,如电子邮件链、网站、非同行评审的预印本和新闻稿。护理模式变得特殊,并经常纳入由这些非传统信息来源驱动的未经证实的干预措施。本报告评估了卫生系统在建立多学科委员会并赋予其权力以制定、实施和监测针对COVID-19患者的循证标准化方案方面所做的努力。方法:本报告描述了委员会的组成、范围及其与卫生系统药学和治疗学委员会、研究团队和规划COVID-19管理其他方面的其他工作组的重要互动。它说明了委员会是如何被用来向受训者展示批判性审查证据的过程和价值的,即使是在混乱的环境中。结果:数据显示,成功的干预措施减少了某些实验室检查的过度订购,减少了非推荐疗法,并迅速采用了循证或指南支持的干预措施。结论:一个多学科委员会专门负责规划、实施和监测最终成为循证决策的标准方法,从而更好地关注COVID-19患者的治疗方案和结果。所提出的数据表明,一个委员会可以取得成功,因为它既能适应,又能适用于今后类似的紧急情况。版权所有©2022特纳怀特通信公司。版权所有。
{"title":"A COVID-19 Clinical Management Committee to Standardize Care in a 2-Hospital System","authors":"Meisenberg","doi":"10.12788/jcom.0079","DOIUrl":"https://doi.org/10.12788/jcom.0079","url":null,"abstract":"Objective: The COVID-19 pandemic has been a challenge for hospital medical staffs worldwide due to high volumes of patients acutely ill with novel syndromes and prevailing uncertainty regarding optimum supportive and therapeutic interventions. Additionally, the response to this crisis was driven by a plethora of nontraditional information sources, such as email chains, websites, non-peer-reviewed preprints, and press releases. Care patterns became idiosyncratic and often incorporated unproven interventions driven by these nontraditional information sources. This report evaluates the efforts of a health system to create and empower a multidisciplinary committee to develop, implement, and monitor evidence-based, standardized protocols for patients with COVID-19. Method(s): This report describes the composition of the committee, its scope, and its important interactions with the health system pharmacy and therapeutics committee, research teams, and other work groups planning other aspects of COVID-19 management. It illustrates how the committee was used to demonstrate for trainees the process and value of critically examining evidence, even in a chaotic environment. Result(s): Data show successful interventions in reducing excessive ordering of certain laboratory tests, reduction of nonrecommended therapies, and rapid uptake of evidence-based or guidelines-supported interventions. Conclusion(s): A multidisciplinary committee dedicated solely to planning, implementing, and monitoring standard approaches that eventually became evidence-based decision-making led to an improved focus on treatment options and outcomes for COVID-19 patients. Data presented illustrate the attainable success of a committee that is both adaptable and suitable for similar emergencies in the future. Copyright © 2022 Turner White Communications Inc.. All rights reserved.","PeriodicalId":15393,"journal":{"name":"Journal of Clinical Outcomes Management","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43899837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intervention in Acute Hospital Unit Reduces Delirium Incidence for Older Adults, Has No Effect on Length of Stay, Other Complications 急性病房干预减少老年人谵妄发生率,对住院时间和其他并发症无影响
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.12788/jcom.0083
Hung
{"title":"Intervention in Acute Hospital Unit Reduces Delirium Incidence for Older Adults, Has No Effect on Length of Stay, Other Complications","authors":"Hung","doi":"10.12788/jcom.0083","DOIUrl":"https://doi.org/10.12788/jcom.0083","url":null,"abstract":"","PeriodicalId":15393,"journal":{"name":"Journal of Clinical Outcomes Management","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43545517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Structural Ableism: Defining Standards of Care Amid Crisis and Inequity 结构性消融:在危机和不公平中定义护理标准
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.12788/jcom.0081
Gregory D. M. D. M. B. A. Snyder
Health care delivered during a pandemic instantiates medicine's perspectives on the value of human life in clinical scenarios where resource allocation is limited. The COVID-19 pandemic has fostered dialogue and debate around the ethical principles that underly such resource allocation, which generally balance utilitarian optimization of resources, equality or equity in health access, the instrumental value of individuals as agents in society, and prioritizing the "worst off" in their natural history of disease.' State legislatures and health systems have responded to the challeges posed by COVID-19 by considering both the scarcity of intensive care resources, such as mechanical ventilation and hemodialysis, and the clinical criteria to be used for determining which patients should receive said resources. These crisis guidelines have yielded several concerning themes vis-a-vis equitable distribution of health care resources, particularly when the disability status of patients is considered alongside life-expectancy or quality of life. Crisis standards of care (CSQ prioritize population-level health under a utilitarian paradigm, explicitly maximizing "life-years'' within a population of patients rather than the life of any individual patient.· Debated during initial COVID surges, these CSC guidelines have recently been enacted at the state level in several settings, including Alaska and Idaho.
大流行期间提供的卫生保健体现了医学在资源分配有限的临床情况下对人类生命价值的看法。2019冠状病毒病大流行促进了围绕这种资源分配背后的伦理原则的对话和辩论,这些原则通常平衡资源的功利主义优化、获得卫生服务的平等或公平、个人作为社会行动者的工具价值,以及在疾病的自然史中优先考虑“最贫穷的人”。州立法机构和卫生系统已经对COVID-19带来的挑战做出了回应,既考虑了机械通气和血液透析等重症监护资源的稀缺,也考虑了用于确定哪些患者应该获得这些资源的临床标准。这些危机准则产生了若干与公平分配保健资源有关的主题,特别是在将患者的残疾状况与预期寿命或生活质量一并考虑的情况下。危机护理标准(CSQ)在功利主义范式下优先考虑人群水平的健康,明确最大化患者群体中的“生命年”,而不是任何个体患者的生命。·在最初的COVID激增期间进行了辩论,这些CSC指南最近已在包括阿拉斯加州和爱达荷州在内的几个州颁布。
{"title":"Structural Ableism: Defining Standards of Care Amid Crisis and Inequity","authors":"Gregory D. M. D. M. B. A. Snyder","doi":"10.12788/jcom.0081","DOIUrl":"https://doi.org/10.12788/jcom.0081","url":null,"abstract":"Health care delivered during a pandemic instantiates medicine's perspectives on the value of human life in clinical scenarios where resource allocation is limited. The COVID-19 pandemic has fostered dialogue and debate around the ethical principles that underly such resource allocation, which generally balance utilitarian optimization of resources, equality or equity in health access, the instrumental value of individuals as agents in society, and prioritizing the \"worst off\" in their natural history of disease.' State legislatures and health systems have responded to the challeges posed by COVID-19 by considering both the scarcity of intensive care resources, such as mechanical ventilation and hemodialysis, and the clinical criteria to be used for determining which patients should receive said resources. These crisis guidelines have yielded several concerning themes vis-a-vis equitable distribution of health care resources, particularly when the disability status of patients is considered alongside life-expectancy or quality of life. Crisis standards of care (CSQ prioritize population-level health under a utilitarian paradigm, explicitly maximizing \"life-years'' within a population of patients rather than the life of any individual patient.· Debated during initial COVID surges, these CSC guidelines have recently been enacted at the state level in several settings, including Alaska and Idaho.","PeriodicalId":15393,"journal":{"name":"Journal of Clinical Outcomes Management","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41687014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Role and Experience of a Subintensive Care Unit in Caring for Patients With COVID-19 in Italy: The CO-RESP Study 意大利亚重症监护病房在照顾新冠肺炎患者中的作用和经验:CO-REP研究
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.12788/jcom.0080
Abram
Objective: This retrospective and prospective cohort study was designed to describe the characteristics, treatments, and outcomes of patients with SARS-CoV-2 infection (COVID-19) admitted to subintensive care units (SICU) and to identify the variables associated with outcomes. SICUs have been extremely stressed during the pandemic, but most data regarding critically ill COVID-19 patients come from intensive care units (ICUs). Studies about COVID-19 patients in SICUs are lacking. Setting and participants: The study included 88 COVID-19 patients admitted to our SICU in Cuneo, Italy, between March and May 2020. Measurements: Clinical and ventilatory data were collected, and patients were divided by outcome. Multivariable logistic regression analysis examined the variables associated with negative outcomes (transfer to the ICU, palliation, or death in a SICU). Results: A total of 60 patients (68%) had a positive outcome, and 28 patients (32%) had a negative outcome;69 patients (78%) underwent continuous positive airway pressure (CPAP). Pronation (n=37 [42%]) had been more frequently adopted in patients who had a positive outcome vs a negative outcome (n=30 [50%] vs n=7 [25%];P=.048), and the median (interquartile range) Pao2 /Fio2 ratio after 6 hours of prone positioning was lower in patients who had a negative outcome vs a positive outcome (144 [140-168] vs 249 [195268], P=.006). Independent predictors of a negative outcome were diabetes (odds ratio [OR], 8.22;95% CI, 1.50-44.70;P=.015), higher D-dimer (OR, 1.28;95% CI, 1.04-1.57;P=.019), higher lactate dehydrogenase level (OR, 1.003;95% CI, 1.000-1.006;P=.039), and lower lymphocytes count (OR, 0.996;95% CI, 0.993-0.999;P=.004). Conclusion: SICUs have a fundamental role in the treatment of critically ill patients with COVID-19, who require longterm CPAP and pronation cycles. Diabetes, lymphopenia, and high D-dimer and LDH levels are associated with negative outcomes.
目的:本回顾性和前瞻性队列研究旨在描述入住亚重症监护病房(SICU)的SARS-CoV-2感染(COVID-19)患者的特征、治疗和结局,并确定与结果相关的变量。疫情期间,重症监护病房承受着极大压力,但大多数关于COVID-19重症患者的数据来自重症监护病房(icu)。关于sicu中COVID-19患者的研究缺乏。环境和参与者:该研究包括2020年3月至5月期间在意大利库尼奥的SICU收治的88名COVID-19患者。测量方法:收集临床和通气数据,并按结果对患者进行分组。多变量logistic回归分析检查了与负面结果相关的变量(转入ICU、缓解或在SICU中死亡)。结果:60例(68%)患者出现阳性结果,28例(32%)患者出现阴性结果;69例(78%)患者接受了持续气道正压通气(CPAP)治疗。结果阳性的患者比结果阴性的患者更常采用内旋(n=37 [42%]) (n=30 [50%] vs n=7 [25%];P= 0.048),结果阴性的患者俯卧位6小时后Pao2 /Fio2比值中位数(四分位数范围)低于结果阳性的患者(144 [140-168]vs 249 [195268], P= 0.006)。阴性结果的独立预测因子为糖尿病(比值比[OR], 8.22;95% CI, 1.50-44.70;P= 0.015)、较高的d -二聚体(OR, 1.28;95% CI, 1.04-1.57;P= 0.019)、较高的乳酸脱氢酶水平(OR, 1.003;95% CI, 1.000-1.006;P= 0.039)和较低的淋巴细胞计数(OR, 0.996;95% CI, 0.993-0.999;P= 0.004)。结论:sicu在需要长期CPAP和旋前周期的COVID-19危重患者的治疗中具有基础性作用。糖尿病、淋巴细胞减少症、高d -二聚体和LDH水平与负面结果相关。
{"title":"Role and Experience of a Subintensive Care Unit in Caring for Patients With COVID-19 in Italy: The CO-RESP Study","authors":"Abram","doi":"10.12788/jcom.0080","DOIUrl":"https://doi.org/10.12788/jcom.0080","url":null,"abstract":"Objective: This retrospective and prospective cohort study was designed to describe the characteristics, treatments, and outcomes of patients with SARS-CoV-2 infection (COVID-19) admitted to subintensive care units (SICU) and to identify the variables associated with outcomes. SICUs have been extremely stressed during the pandemic, but most data regarding critically ill COVID-19 patients come from intensive care units (ICUs). Studies about COVID-19 patients in SICUs are lacking. Setting and participants: The study included 88 COVID-19 patients admitted to our SICU in Cuneo, Italy, between March and May 2020. Measurements: Clinical and ventilatory data were collected, and patients were divided by outcome. Multivariable logistic regression analysis examined the variables associated with negative outcomes (transfer to the ICU, palliation, or death in a SICU). Results: A total of 60 patients (68%) had a positive outcome, and 28 patients (32%) had a negative outcome;69 patients (78%) underwent continuous positive airway pressure (CPAP). Pronation (n=37 [42%]) had been more frequently adopted in patients who had a positive outcome vs a negative outcome (n=30 [50%] vs n=7 [25%];P=.048), and the median (interquartile range) Pao2 /Fio2 ratio after 6 hours of prone positioning was lower in patients who had a negative outcome vs a positive outcome (144 [140-168] vs 249 [195268], P=.006). Independent predictors of a negative outcome were diabetes (odds ratio [OR], 8.22;95% CI, 1.50-44.70;P=.015), higher D-dimer (OR, 1.28;95% CI, 1.04-1.57;P=.019), higher lactate dehydrogenase level (OR, 1.003;95% CI, 1.000-1.006;P=.039), and lower lymphocytes count (OR, 0.996;95% CI, 0.993-0.999;P=.004). Conclusion: SICUs have a fundamental role in the treatment of critically ill patients with COVID-19, who require longterm CPAP and pronation cycles. Diabetes, lymphopenia, and high D-dimer and LDH levels are associated with negative outcomes.","PeriodicalId":15393,"journal":{"name":"Journal of Clinical Outcomes Management","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41360045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Fractional Flow Reserve–Guided PCI and Coronary Bypass Surgery in 3-Vessel Disease 分流血流储备引导下的PCI与冠状动脉旁路手术治疗三支血管疾病的比较
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.12788/jcom.0082
Kanake
{"title":"Comparison of Fractional Flow Reserve–Guided PCI and Coronary Bypass Surgery in 3-Vessel Disease","authors":"Kanake","doi":"10.12788/jcom.0082","DOIUrl":"https://doi.org/10.12788/jcom.0082","url":null,"abstract":"","PeriodicalId":15393,"journal":{"name":"Journal of Clinical Outcomes Management","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47280076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful COVID-19 Surge Management With Monoclonal Antibody Infusion in Emergency Department Patients 急诊科患者输注单克隆抗体成功应对新冠肺炎激增
Q4 Medicine Pub Date : 2021-12-03 DOI: 10.12788/jcom.0078
Chow
Background: The COVID-19 pandemic has placed substantial strain on hospital resources and has been responsible for more than 733000 deaths in the United States. The US Food and Drug Administration has granted emergency use authorization (EUA) for monoclonal antibody (mAb) therapy for patients with early-stage high-risk COVID-19. Methods: In this retrospective cohort study, we studied the emergency department (ED) during a massive COVID-19 surge in Orange County, California, from December 4, 2020, to January 29, 2021, as a potential setting for efficient mAb delivery by evaluating the impact of bamlanivimab use in high-risk COVID-19 patients. All patients included in this study had positive results on nucleic acid amplification detection from nasopharyngeal or throat swabs, presented with 1 or more mild or moderate symptoms, and met EUA criteria for mAb treatment. The primary outcome analyzed among this cohort of ED patients was overall improvement, which included subsequent ED/hospital visits, inpatient hospitalization, and death related to COVID-19. Results: We identified 1278 ED patients with COVID-19 not treated with bamlanivimab and 73 patients with COVID-19 treated with bamlanivimab during the treatment period. Of these patients, 239 control patients and 63 treatment patients met EUA criteria. Overall, 7.9% (5/63) of patients receiving bamlanivimab had a subsequent ED/hospital visit, hospitalization, or death compared with 19.2% (46/239) in the control group (P=.03). Conclusion: Targeting ED patients for mAb treatment may be an effective strategy to prevent progression to severe COVID-19 illness and substantially reduce the composite end point of repeat ED visits, hospitalizations, and deaths, especially for individuals of underserved populations who may not have access to ambulatory care.
背景:COVID-19大流行给医院资源带来了巨大压力,并已导致美国超过73.3万人死亡。美国食品和药物管理局(fda)批准了用于早期高风险COVID-19患者的单克隆抗体(mAb)治疗的紧急使用授权(EUA)。方法:在这项回顾性队列研究中,我们研究了2020年12月4日至2021年1月29日加利福尼亚州奥兰治县COVID-19大规模激增期间的急诊科(ED),通过评估bamlanivimab对高危COVID-19患者的影响,作为有效提供单抗的潜在环境。本研究纳入的所有患者鼻咽或咽拭子核酸扩增检测结果均为阳性,出现1项或1项以上轻、中度症状,符合mAb治疗的EUA标准。在这组急诊科患者中分析的主要结局是总体改善,包括随后的急诊科/医院就诊、住院治疗和与COVID-19相关的死亡。结果:我们确定了1278例未使用巴兰尼韦单抗治疗的ED患者和73例在治疗期间使用巴兰尼韦单抗治疗的COVID-19患者。其中对照组239例,治疗组63例符合EUA标准。总体而言,7.9%(5/63)接受bamlanivimab治疗的患者随后出现急症/住院、住院或死亡,而对照组的这一比例为19.2% (46/239)(P= 0.03)。结论:针对ED患者进行单抗治疗可能是一种有效的策略,可以预防进展为严重的COVID-19疾病,并大大减少重复ED就诊,住院和死亡的复合终点,特别是对于可能无法获得门诊护理的服务不足人群的个体。
{"title":"Successful COVID-19 Surge Management With Monoclonal Antibody Infusion in Emergency Department Patients","authors":"Chow","doi":"10.12788/jcom.0078","DOIUrl":"https://doi.org/10.12788/jcom.0078","url":null,"abstract":"Background: The COVID-19 pandemic has placed substantial strain on hospital resources and has been responsible for more than 733000 deaths in the United States. The US Food and Drug Administration has granted emergency use authorization (EUA) for monoclonal antibody (mAb) therapy for patients with early-stage high-risk COVID-19. Methods: In this retrospective cohort study, we studied the emergency department (ED) during a massive COVID-19 surge in Orange County, California, from December 4, 2020, to January 29, 2021, as a potential setting for efficient mAb delivery by evaluating the impact of bamlanivimab use in high-risk COVID-19 patients. All patients included in this study had positive results on nucleic acid amplification detection from nasopharyngeal or throat swabs, presented with 1 or more mild or moderate symptoms, and met EUA criteria for mAb treatment. The primary outcome analyzed among this cohort of ED patients was overall improvement, which included subsequent ED/hospital visits, inpatient hospitalization, and death related to COVID-19. Results: We identified 1278 ED patients with COVID-19 not treated with bamlanivimab and 73 patients with COVID-19 treated with bamlanivimab during the treatment period. Of these patients, 239 control patients and 63 treatment patients met EUA criteria. Overall, 7.9% (5/63) of patients receiving bamlanivimab had a subsequent ED/hospital visit, hospitalization, or death compared with 19.2% (46/239) in the control group (P=.03). Conclusion: Targeting ED patients for mAb treatment may be an effective strategy to prevent progression to severe COVID-19 illness and substantially reduce the composite end point of repeat ED visits, hospitalizations, and deaths, especially for individuals of underserved populations who may not have access to ambulatory care.","PeriodicalId":15393,"journal":{"name":"Journal of Clinical Outcomes Management","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43501273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative Code Status Discussion in Older Adults: Are We Doing Enough? 老年人术前代码状态讨论:我们做得够吗?
Q4 Medicine Pub Date : 2021-11-01 DOI: 10.12788/jcom.0076
Ko
{"title":"Preoperative Code Status Discussion in Older Adults: Are We Doing Enough?","authors":"Ko","doi":"10.12788/jcom.0076","DOIUrl":"https://doi.org/10.12788/jcom.0076","url":null,"abstract":"","PeriodicalId":15393,"journal":{"name":"Journal of Clinical Outcomes Management","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48249748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of Same-Day Naloxone Availability in New Mexico Pharmacies 新墨西哥州药房当天纳洛酮可用性评估
Q4 Medicine Pub Date : 2021-11-01 DOI: 10.12788/jcom.0070
Haponyuk
{"title":"Assessment of Same-Day Naloxone Availability in New Mexico Pharmacies","authors":"Haponyuk","doi":"10.12788/jcom.0070","DOIUrl":"https://doi.org/10.12788/jcom.0070","url":null,"abstract":"","PeriodicalId":15393,"journal":{"name":"Journal of Clinical Outcomes Management","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43326230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FFR-Guided or Angiography-Guided Nonculprit Lesion PCI in Patients With STEMI Without Cardiogenic Shock 无心源性休克STEMI患者ffr引导或血管造影引导下非罪魁祸首病变PCI治疗
Q4 Medicine Pub Date : 2021-11-01 DOI: 10.12788/jcom.0075
Kanake
{"title":"FFR-Guided or Angiography-Guided Nonculprit Lesion PCI in Patients With STEMI Without Cardiogenic Shock","authors":"Kanake","doi":"10.12788/jcom.0075","DOIUrl":"https://doi.org/10.12788/jcom.0075","url":null,"abstract":"","PeriodicalId":15393,"journal":{"name":"Journal of Clinical Outcomes Management","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45853196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Use of Nasogastric Tube Bridle Kits in COVID-19 Intensive Care Unit Patients 鼻导管支架在新冠肺炎重症监护病房患者中的应用
Q4 Medicine Pub Date : 2021-11-01 DOI: 10.12788/jcom.0072
Atkar
Objective: To ascertain the extent of nasogastric tube (NGT) dislodgment in COVID-19 intensive care unit (ICU) patients after the introduction of NGT bridle kits as a standard of practice, to see whether this would reduce the number of NGT insertions, patient irradiation, missed feeds, and overall cost. Background: Nasogastric feeding is the mainstay of enteral feeding for ICU patients. The usual standard of practice is to secure the tube using adhesive tape. Studies show this method has a 40% to 48% dislodgment rate. The COVID-19 ICU patient population may be at even greater risk due to the need for proning, long duration of invasive ventilation, and emergence delirium. Design: This was a 2-cycle quality improvement project. The first cycle was done retrospectively, looking at the contemporaneous standard of practice where bridle kits were not used. This gave an objective measure of the extent of NGT displacement, associated costs, and missed feeds. The second cycle was carried out prospectively, with the use of NGT bridle kits as the new standard of practice. Setting: A large United Kingdom teaching hospital with a 100-bed, single-floor ICU. Participants: Patients admitted to the ICU with COVID-19 who subsequently required sedation and invasive ventilation. Measurements: Measurements included days of feeding required, hours of feeding missed due to NGT dislodgment, total number of nasogastric tubes required per ICU stay, and number of chest radiographs for NGT position confirmation. NGT-related pressure sores were also recorded. Results: When compared to the bridled group, the unbridled group required a higher number of NGTs (2.5 vs 1.3;P<.001) and chest radiographs (3.4 vs 1.6;P<.001), had more hours of feeding missed (11.8 vs 5.0), and accumulated a slightly higher total cost (cost of NGT, chest radiographs +/- bridle kit: £211.67 vs £210, [US $284.25 vs US $282.01]). Conclusions: The use of NGT bridle kits reduces the number of NGT insertions patients require and subsequently reduces the number of chest radiographs for each patient. These patients also miss fewer feeds, with no appreciable increase in cost.
目的:确定新冠肺炎重症监护室(ICU)患者在引入NGT套具作为实践标准后鼻肠管(NGT)移位的程度,以了解这是否会减少NGT插入次数、患者照射、误食和总体成本。背景:鼻饲是ICU患者肠内营养的主要方式。通常的做法标准是用胶带固定管子。研究表明,这种方法有40%到48%的去除率。新冠肺炎重症监护室患者群体可能面临更大的风险,因为需要内旋、长时间的有创通气和出现谵妄。设计:这是一个两个周期的质量改进项目。第一个周期是回顾性的,着眼于当时没有使用缰绳套件的实践标准。这提供了NGT位移程度、相关成本和漏投的客观衡量标准。第二个周期是前瞻性地进行的,使用NGT缰绳套件作为新的实践标准。环境:英国一家大型教学医院,设有100张床位的单层ICU。参与者:新冠肺炎患者入住ICU,随后需要镇静和有创通气。测量:测量包括所需进食天数、因NGT移位而错过进食的小时数、每次ICU住院所需鼻胃导管的总数以及用于确认NGT位置的胸部X光片数量。还记录了NGT相关的压疮。结果:与束缚组相比,无束缚组需要更高数量的NGT(2.5 vs 1.3;P<.001)和胸部X线片(3.4 vs 1.6;P<0.001),错过喂养的时间更长(11.8 vs 5.0),并积累了略高的总成本(NGT、胸部X光片+/-套带的成本:211.67英镑vs 210英镑,284.25美元vs 282.01美元])。结论:NGT套带的使用减少了患者所需的NGT插入次数,从而减少了每位患者的胸部X光照片数量。这些患者错过的饲料也更少,成本也没有明显增加。
{"title":"The Use of Nasogastric Tube Bridle Kits in COVID-19 Intensive Care Unit Patients","authors":"Atkar","doi":"10.12788/jcom.0072","DOIUrl":"https://doi.org/10.12788/jcom.0072","url":null,"abstract":"Objective: To ascertain the extent of nasogastric tube (NGT) dislodgment in COVID-19 intensive care unit (ICU) patients after the introduction of NGT bridle kits as a standard of practice, to see whether this would reduce the number of NGT insertions, patient irradiation, missed feeds, and overall cost. Background: Nasogastric feeding is the mainstay of enteral feeding for ICU patients. The usual standard of practice is to secure the tube using adhesive tape. Studies show this method has a 40% to 48% dislodgment rate. The COVID-19 ICU patient population may be at even greater risk due to the need for proning, long duration of invasive ventilation, and emergence delirium. Design: This was a 2-cycle quality improvement project. The first cycle was done retrospectively, looking at the contemporaneous standard of practice where bridle kits were not used. This gave an objective measure of the extent of NGT displacement, associated costs, and missed feeds. The second cycle was carried out prospectively, with the use of NGT bridle kits as the new standard of practice. Setting: A large United Kingdom teaching hospital with a 100-bed, single-floor ICU. Participants: Patients admitted to the ICU with COVID-19 who subsequently required sedation and invasive ventilation. Measurements: Measurements included days of feeding required, hours of feeding missed due to NGT dislodgment, total number of nasogastric tubes required per ICU stay, and number of chest radiographs for NGT position confirmation. NGT-related pressure sores were also recorded. Results: When compared to the bridled group, the unbridled group required a higher number of NGTs (2.5 vs 1.3;P<.001) and chest radiographs (3.4 vs 1.6;P<.001), had more hours of feeding missed (11.8 vs 5.0), and accumulated a slightly higher total cost (cost of NGT, chest radiographs +/- bridle kit: £211.67 vs £210, [US $284.25 vs US $282.01]). Conclusions: The use of NGT bridle kits reduces the number of NGT insertions patients require and subsequently reduces the number of chest radiographs for each patient. These patients also miss fewer feeds, with no appreciable increase in cost.","PeriodicalId":15393,"journal":{"name":"Journal of Clinical Outcomes Management","volume":"114 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41299935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical Outcomes Management
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1